Sivaguru et al. evaluated the evolution of calcium oxalate stones using geobiology [1] . They observed how calcium oxalate stones undergo multiple events of dissolution during crystallization and growth in the kidney based on super-resolution auto-fluorescence images. They concluded that their results "modify the long-held working assumption that calcium oxalate is strongly insoluble in vivo". We disagree with this statement since their findings are nothing new under the sun.
The concept that calcium oxalate monohydrate (COM) stones can be either formed by primary crystallization or by dehydration of calcium oxalate dihydrate (COD) stones has been described more than 50 years ago. In 1962, Murphy and Pyrah described the transition and recrystallization of COD to COM after analysis of stones with aggregates of monohydrate crystals in the centre and dihydrate crystals in the periphery [2] . They reported that the original deposition was COD, which later crystallized to COM. This was illustrated with a picture showing a COD crystal that was partially recrystallized to COM. This well-known phenomenon was also described by Cifuentes Delatte et al. in 1972 using polarization microscopy and infrared spectroscopy [3] . They reported the transformation of COD to COM in the centre of stones that became covered by the apposition of new COD layers. They additionally found that crystals in a transition phase did neither have the typical morphological aspects of COD nor COM, but that these crystals clearly corresponded to COM with infrared spectroscopy. After incubation experiments and scanning electron microscopy, Berg et al. found in 1979 that COD crystals dehydrate to COM crystals via dissolution and recrystallization, starting at the corners and edges [4] .
This dissolution and conversion process from COD to COM must be taken into account when making relationships between stone morphology, crystalline composition and possible etiopathogenic factors [5] . However, stating that "these observations open a fundamentally new paradigm for clinical approaches that include in vivo stone dissolution" is premature, since this study only confirms research from the last half century.
